Your browser doesn't support javascript.
Estimating asymptomatic SARS-CoV-2 infections in a geographic area of low disease incidence.
Caturano, Valeria; Manti, Barbara; Carbone, Fortunata; Lasorsa, Vito Alessandro; Colicchio, Roberta; Capasso, Mario; Leonardi, Antonio; Matarese, Giuseppe; Russo, Tommaso; Salvatore, Paola.
  • Caturano V; Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy.
  • Manti B; Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy.
  • Carbone F; Istituto di Endocrinologia e Oncologia Sperimentale, Consiglio Nazionale Delle Ricerche (IEOS-CNR), Naples, Italy.
  • Lasorsa VA; Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy.
  • Colicchio R; CEINGE Biotecnologie Avanzate s.c.ar.l., Naples, Italy.
  • Capasso M; Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy.
  • Leonardi A; Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy.
  • Matarese G; CEINGE Biotecnologie Avanzate s.c.ar.l., Naples, Italy.
  • Russo T; Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy.
  • Salvatore P; Department of Molecular Medicine and Medical Biotechnology, University of Napoli Federico II, Via S. Pansini 5, 80131, Naples, Italy.
BMC Infect Dis ; 21(1): 350, 2021 Apr 15.
Article in English | MEDLINE | ID: covidwho-1186555
ABSTRACT

BACKGROUND:

The SARS-CoV-2 infection has emerged as a rapidly spreading infection. Today it is relatively easy to isolate Covid-19 symptomatic cases, while remains problematic to control the disease spread by infected but symptom-free individuals. The control of this possible path of contagion requires drastic measures of social distancing, which imply the suspension of most activities and generate economic and social issues. This study is aimed at estimating the percentage of asymptomatic SARS-CoV-2 infection in a geographic area with relatively low incidence of Covid-19.

METHODS:

Blood serum samples from 388 healthy volunteers were analyzed for the presence of anti-SARS-CoV-2 IgG by using an ELISA assay based on recombinant viral nucleocapsid protein.

RESULTS:

We found that 7 out of 388 healthy volunteers, who declared no symptoms of Covid-19, like fever, cough, fatigue etc., in the preceding 5 months, have bona fide serum anti-SARS-CoV-2 IgG, that is 1.8% of the asymptomatic population (95% confidence interval 0.69-2.91%).

CONCLUSIONS:

The estimated range of asymptomatic individuals with anti-SARS-CoV-2 IgG should be between 26,565 and 112, 350. In the same geographic area, there are 4665 symptomatic diagnosed cases.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asymptomatic Infections / COVID-19 / Antibodies, Viral Type of study: Observational study Limits: Adult / Aged / Humans / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S12879-021-06054-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Asymptomatic Infections / COVID-19 / Antibodies, Viral Type of study: Observational study Limits: Adult / Aged / Humans / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S12879-021-06054-2